FDA hits the ground running with 12 first-quarter 2017 drug approvals

Fierce Pharma ------- After a big slowdown in 2016, FDA new drug approvals got off to a hot start in 2017. During the first quarter, the regulator signed off on more new meds than during the same period of any year in recent history. So far this year, the agency has endorsed 13 new drugs, including blockbusters-to-be Ocrevus from Roche and Dupixent from partners Sanofi and Regeneron. With 12 new drugs approved in the first quarter, FDA approval action this year bested any since 2011, according to the FDA’s website. In recent years, the agency has signed off on between 6 and 10 new drugs in the first quarter. To learn more click on the picture below to read the article.